Denosumab or oral bisphosphonates in primary osteoporosis: a “real-life” study

ConclusionsIn postmenopausal PO females, denosumab was more effective than oral bisphosphonates in increasing BMD and reducing bone turnover and the number of inadequate responder patients.

http://link.springer.com/10.1007/s40618-018-0829-9

Source: Journal of Endocrinological Investigation - January 16, 2018 Category: Endocrinology Source Type: research